The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy

Immunology Letters

Volumn 100, Issue 1, 2005, Pages 42-55

  Yu, Karl O A ^a   Porcelli, Steven A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

CD1; Cytokines; Glycolipid; NKT cell

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; CD1D ANTIGEN; GALACTOSYLCERAMIDE; GLYCOLIPID;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; HUMAN; IMMUNOTHERAPY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD1; AUTOIMMUNE DISEASES; BACTERIAL INFECTIONS; CYTOKINES; GLUCOSYLCERAMIDES; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; PROTOZOAN INFECTIONS; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 24344506642     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.06.010     Document Type: Review

References (123)

1. D.I. Godfrey, H.R. MacDonald, M. Kronenberg, M.J. Smyth, and L. Van Kaer NKT cells: what's in a name Nat Rev Immunol 4 2004 231 237
2. +-like thymocytes in the NOD mouse Eur J Immunol 26 1996 2989 2998
3. K.J. Hammond, D.G. Pellicci, L.D. Poulton, O.V. Naidenko, A.A. Scalzo, A.G. Baxter, and D.I. Godfrey CD1d-restricted NKT cells: an interstrain comparison J Immunol 167 2001 1164 1173
4. B. Wang, Y.B. Geng, and C.R. Wang CD1-restricted NK T cells protect non-obese diabetic mice from developing diabetes J Exp Med 194 2001 313 320
5. S. Joyce, A.S. Woods, J.W. Yewdell, J.R. Bennink, A.D. De Silva, A. Boesteanu, S.P. Balk, R.J. Cotter, and R.R. Brutkiewicz Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol Science 279 1998 1541 1544
6. J.E. Gumperz, C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y. Koezuka, S.A. Porcelli, S. Cardell, M.B. Brenner, and S.M. Behar Murine CD1d-restricted T cell recognition of cellular lipids Immunity 12 2000 211 221
7. D. Zhou, J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y.P. Wu, T. Yamashita, S. Teneberg, D. Wang, R.L. Proia, S.B. Levery, P.B. Savage, L. Teyton, and A. Bendelac Lysosomal glycosphingolipid recognition by NKT cells Science 306 2004 1786 1789
8. J. Mattner, K.L. Debord, N. Ismail, R.D. Goff, C. Cantu III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, K. Hoebe, O. Schneewind, D. Walker, B. Beutler, L. Teyton, P.B. Savage, and A. Bendelac Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections Nature 434 2005 525 529
9. Y. Kinjo, D. Wu, G. Kim, G.W. Xing, M.A. Poles, D.D. Ho, M. Tsuji, K. Kawahara, C.H. Wong, and M. Kronenberg Recognition of bacterial glycosphingolipids by natural killer T cells Nature 434 2005 520 525
10. K. Fischer, E. Scotet, M. Niemeyer, H. Koebernick, J. Zerrahn, S. Maillet, R. Hurwitz, M. Kursar, M. Bonneville, S.H. Kaufmann, and U.E. Schaible Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells Proc Natl Acad Sci USA 2004
11. M. Brigl, L. Bry, S.C. Kent, J.E. Gumperz, and M.B. Brenner Mechanism of CD1d-restricted natural killer T cell activation during microbial infection Nat Immunol 4 2003 1230 1237
12. T. Kawano, J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, and M. Taniguchi CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides Science 278 1997 1626 1629
13. E. Kobayashi, K. Motoki, T. Uchida, H. Fukushima, and Y. Koezuka KRN7000, a novel immunomodulator, and its antitumor activities Oncol Res 7 1995 529 534
14. K. Benlagha, A. Weiss, A. Beavis, L. Teyton, and A. Bendelac In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers J Exp Med 191 2000 1895 1903
15. J.L. Matsuda, O.V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C.R. Wang, Y. Koezuka, and M. Kronenberg Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers J Exp Med 192 2000 741 754
16. S. Hong, M.T. Wilson, I. Serizawa, L. Wu, N. Singh, O.V. Naidenko, T. Miura, T. Haba, D.C. Scherer, J. Wei, M. Kronenberg, Y. Koezuka, and L. Van Kaer The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice Nat Med 7 2001 1052 1056
17. S. Sharif, G.A. Arreaza, P. Zucker, Q.S. Mi, J. Sondhi, O.V. Naidenko, M. Kronenberg, Y. Koezuka, T.L. Delovitch, J.M. Gombert, M. Leite-De-Moraes, C. Gouarin, R. Zhu, A. Hameg, T. Nakayama, M. Taniguchi, F. Lepault, A. Lehuen, J.F. Bach, and A. Herbelin Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes Nat Med 7 2001 1057 1062
18. A. Chackerian, J. Alt, V. Perera, and S.M. Behar Activation of NKT cells protects mice from tuberculosis Infect Immun 70 2002 6302 6309
19. E. Tupin, A. Nicoletti, R. Elhage, M. Rudling, H.G. Ljunggren, G.K. Hansson, and G.P. Berne CD1d-dependent activation of NKT cells aggravates atherosclerosis J Exp Med 199 2004 417 422
20. Y. Nakai, K. Iwabuchi, S. Fujii, N. Ishimori, N. Dashtsoodol, K. Watano, T. Mishima, C. Iwabuchi, S. Tanaka, J.S. Bezbradica, T. Nakayama, M. Taniguchi, S. Miyake, T. Yamamura, A. Kitabatake, S. Joyce, L. Van Kaer, and K. Onoe Natural killer T cells accelerate atherogenesis in mice Blood 104 2004 2051 2059
21. D. Zeng, Y. Liu, S. Sidobre, M. Kronenberg, and S. Strober Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus J Clin Invest 112 2003 1211 1222
22. J. Schmieg, G. Yang, R.W. Franck, N. Van Rooijen, and M. Tsuji Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion Proc Natl Acad Sci USA 102 2005 1127 1132
23. J.L. Matsuda, L. Gapin, J.L. Baron, S. Sidobre, D.B. Stetson, M. Mohrs, R.M. Locksley, and M. Kronenberg Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo Proc Natl Acad Sci USA 100 2003 8395 8400
24. N.Y. Crowe, A.P. Uldrich, K. Kyparissoudis, K.J. Hammond, Y. Hayakawa, S. Sidobre, R. Keating, M. Kronenberg, M.J. Smyth, and D.I. Godfrey Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells J Immunol 171 2003 4020 4027
25. M.T. Wilson, C. Johansson, D. Olivares-Villagomez, A.K. Singh, A.K. Stanic, C.R. Wang, S. Joyce, M.J. Wick, and L. Van Kaer The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion Proc Natl Acad Sci USA 100 2003 10913 10918
26. C. Carnaud, D. Lee, O. Donnars, S.H. Park, A. Beavis, Y. Koezuka, and A. Bendelac Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells J Immunol 163 1999 4647 4650
27. H. Kitamura, K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, M. Taniguchi, and T. Nishimura The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells J Exp Med 189 1999 1121 1128
28. J.D. Wesley, S.H. Robbins, S. Sidobre, M. Kronenberg, S. Terrizzi, and L. Brossay Cutting edge: IFN-γ signaling to macrophages is required for optimal Vα14i NK T/NK cell cross-talk J Immunol 174 2005 3864 3868
29. S. Fujii, K. Shimizu, C. Smith, L. Bonifaz, and R.M. Steinman Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein J Exp Med 198 2003 267 279
30. H. Kitamura, A. Ohta, M. Sekimoto, M. Sato, K. Iwakabe, M. Nakui, T. Yahata, H. Meng, T. Koda, S. Nishimura, T. Kawano, M. Taniguchi, and T. Nishimura α-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells Cell Immunol 199 2000 37 42
31. N. Singh, S. Hong, D.C. Scherer, I. Serizawa, N. Burdin, M. Kronenberg, Y. Koezuka, and L. Van Kaer Cutting edge: activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype J Immunol 163 1999 2373 2377
32. H2 bias of natural killer T cells Nature 413 2001 531 534
33. S. Oki, A. Chiba, T. Yamamura, and S. Miyake The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells J Clin Invest 113 2004 1631 1640
34. R.D. Goff, Y. Gao, J. Mattner, D. Zhou, N. Yin, C. Cantu III, L. Teyton, A. Bendelac, and P.B. Savage Effects of lipid chain lengths in α-galactosylceramides on cytokine release by natural killer T cells J Am Chem Soc 126 2004 13602 13603
35. A.K. Stanic, R. Shashidharamurthy, J.S. Bezbradica, N. Matsuki, Y. Yoshimura, S. Miyake, E.Y. Choi, T.D. Schell, L. Van Kaer, S.S. Tevethia, D.C. Roopenian, T. Yamamura, and S. Joyce Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Vα14Jα18 natural killer T (iNKT) cell receptor J Immunol 171 2003 4539 4551
36. K.O. Yu, J.S. Im, A. Molano, Y. Dutronc, P.A. Illarionov, C. Forestier, N. Fujiwara, I. Arias, S. Miyake, T. Yamamura, Y.T. Chang, G.S. Besra, and S.A. Porcelli Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides Proc Natl Acad Sci USA 102 2005 3383 3388
37. J. Schmieg, G. Yang, R.W. Franck, and M. Tsuji Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand α-galactosylceramide J Exp Med 198 2003 1631 1641
38. Y. Ueno, S. Tanaka, M. Sumii, S. Miyake, S. Tazuma, M. Taniguchi, T. Yamamura, and K. Chayama Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of Vα14 natural killer T cells in mice Inflamm Bowel Dis 11 2005 35 41
39. J.S. Bezbradica, A.K. Stanic, N. Matsuki, H. Bour-Jordan, J.A. Bluestone, J.W. Thomas, D. Unutmaz, L. Van Kaer, and S. Joyce Distinct roles of dendritic cells and B cells in Vα14Jα18 natural T cell activation in vivo J Immunol 174 2005 4696 4705
40. G.A. Lang, S.D. Maltsev, G.S. Besra, and M.L. Lang Presentation of α-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts Immunology 112 2004 386 396
41. Y.K. Park, J.W. Lee, Y.G. Ko, S. Hong, and S.H. Park Lipid rafts are required for efficient signal transduction by CD1d Biochem Biophys Res Commun 327 2005 1143 1154
42. M. Skold, and S.M. Behar Role of CD1d-restricted NKT cells in microbial immunity Infect Immun 71 2003 5447 5455
43. J. Cui, T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors Science 278 1997 1623 1626
44. N.Y. Crowe, M.J. Smyth, and D.I. Godfrey A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas J Exp Med 196 2002 119 127
45. M. Terabe, S. Matsui, N. Noben-Trauth, H. Chen, C. Watson, D.D. Donaldson, D.P. Carbone, W.E. Paul, and J.A. Berzofsky NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway Nat Immunol 1 2000 515 520
46. A.K. Singh, M.T. Wilson, S. Hong, D. Olivares-Villagomez, C. Du, A.K. Stanic, S. Joyce, S. Sriram, Y. Koezuka, and L. Van Kaer Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis J Exp Med 194 2001 1801 1811
47. J.Q. Yang, A.K. Singh, M.T. Wilson, M. Satoh, A.K. Stanic, J.J. Park, S. Hong, S.D. Gadola, A. Mizutani, S.R. Kakumanu, W.H. Reeves, V. Cerundolo, S. Joyce, L. Van Kaer, and R.R. Singh Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis J Immunol 171 2003 2142 2153
48. H.Y. Kim, H.J. Kim, H.S. Min, S. Kim, W.S. Park, S.H. Park, and D.H. Chung NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor β 1 production J Exp Med 201 2005 41 47
49. J.E. Gumperz, S. Miyake, T. Yamamura, and M.B. Brenner Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining J Exp Med 195 2002 625 636
50. P.T. Lee, K. Benlagha, L. Teyton, and A. Bendelac Distinct functional lineages of human Vα24 natural killer T cells J Exp Med 195 2002 637 641
51. S.Y. Thomas, R. Hou, J.E. Boyson, T.K. Means, C. Hess, D.P. Olson, J.L. Strominger, M.B. Brenner, J.E. Gumperz, S.B. Wilson, and A.D. Luster CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells J Immunol 171 2003 2571 2580
52. E. Pal, T. Tabira, T. Kawano, M. Taniguchi, S. Miyake, and T. Yamamura Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells J Immunol 166 2001 662 668
53. Y. Hayakawa, K. Takeda, H. Yagita, L. Van Kaer, I. Saiki, and K. Okumura Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways J Immunol 166 2001 6012 6018
54. - thymocytes J Autoimmun 10 1997 279 285
55. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10 J Exp Med 187 1998 1047 1056
56. M. Mizuno, M. Masumura, C. Tomi, A. Chiba, S. Oki, T. Yamamura, and S. Miyake Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice J Autoimmun 23 2004 293 300
57. S.P. Berzins, K. Kyparissoudis, D.G. Pellicci, K.J. Hammond, S. Sidobre, A. Baxter, M.J. Smyth, M. Kronenberg, and D.I. Godfrey Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: implications for human studies Immunol Cell Biol 82 2004 247 252
58. P.T. Lee, A. Putnam, K. Benlagha, L. Teyton, P.A. Gottlieb, and A. Bendelac Testing the NKT cell hypothesis of human IDDM pathogenesis J Clin Invest 110 2002 793 800
59. S.B. Wilson, S.C. Kent, K.T. Patton, T. Orban, R.A. Jackson, M. Exley, S. Porcelli, D.A. Schatz, M.A. Atkinson, S.P. Balk, J.L. Strominger, and D.A. Hafler Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes Nature 391 1998 177 181
60. A. Kukreja, G. Cost, J. Marker, C. Zhang, Z. Sun, K. Lin-Su, S. Ten, M. Sanz, M. Exley, B. Wilson, S. Porcelli, and N. Maclaren Multiple immuno-regulatory defects in type-1 diabetes J Clin Invest 109 2002 131 140
61. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage Clin Immunol 100 2001 144 148
62. Z. Illes, T. Kondo, J. Newcombe, N. Oka, T. Tabira, and T. Yamamura Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy J Immunol 164 2000 4375 4381
63. A. Chiba, S. Oki, K. Miyamoto, H. Hashimoto, T. Yamamura, and S. Miyake Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of α-galactosylceramide Arthritis Rheum 50 2004 305 313
64. + double-negative regulatory natural killer T cells in autoimmune diseases Arthritis Rheum 44 2001 1127 1138
65. + B cells at the onset of autoimmune disease in (NZB × NZW)F1 mice Eur J Immunol 32 2002 2551 2561
66. D. Zeng, M.K. Lee, J. Tung, A. Brendolan, and S. Strober Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice J Immunol 164 2000 5000 5004
67. C. Forestier, A. Molano, J.S. Im, Y. Dutronc, P.A. Illarionov, B. Diamond, A. Davidson, G.S. Besra, and S. Porcelli Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black × New Zealand White) F1 mice J Immunol 175 2005 763 770
68. A.K. Singh, J.Q. Yang, V.V. Parekh, J. Wei, C.R. Wang, S. Joyce, R.R. Singh, and L. Van Kaer The natural killer T cell ligand α- galactosylceramide prevents or promotes pristane-induced lupus in mice Eur J Immunol 35 2005 1143 1154
69. J.Q. Yang, V. Saxena, H. Xu, L. Van Kaer, C.R. Wang, and R.R. Singh Repeated α-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice J Immunol 171 2003 4439 4446
70. lpr nice: an example of disease regulation at the organ level J Immunol 167 2001 2985 2990
71. Y. Oishi, T. Sumida, A. Sakamoto, Y. Kita, K. Kurasawa, Y. Nawata, K. Takabayashi, H. Takahashi, S. Yoshida, M. Taniguchi, Y. Saito, and I. Iwamoto Selective reduction and recovery of invariant Vα24JαQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus J Rheumatol 28 2001 275 283
72. T. Sumida, A. Sakamoto, H. Murata, Y. Makino, H. Takahashi, S. Yoshida, K. Nishioka, I. Iwamoto, and M. Taniguchi Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis J Exp Med 182 1995 1163 1168
73. L.P. Ho, B.C. Urban, D.R. Thickett, R.J. Davies, and A.J. McMichael Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis Lancet 365 2005 1062 1072
74. M. Mempel, B. Flageul, F. Suarez, C. Ronet, L. Dubertret, P. Kourilsky, G. Gachelin, and P. Musette Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas Presence of Vα24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Vα repertoire Am J Pathol 157 2000 509 523
75. L.J. Saubermann, P. Beck, Y.P. De Jong, R.S. Pitman, M.S. Ryan, H.S. Kim, M. Exley, S. Snapper, S.P. Balk, S.J. Hagen, O. Kanauchi, K. Motoki, T. Sakai, C. Terhorst, Y. Koezuka, D.K. Podolsky, and R.S. Blumberg Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice Gastroenterology 119 2000 119 128
76. R.A. Campos, M. Szczepanik, A. Itakura, M. Akahira-Azuma, S. Sidobre, M. Kronenberg, and P.W. Askenase Cutaneous immunization rapidly activates liver invariant Vα14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity J Exp Med 198 2003 1785 1796
77. M. Korsgren, C.G. Persson, F. Sundler, T. Bjerke, T. Hansson, B.J. Chambers, S. Hong, L. Van Kaer, H.G. Ljunggren, and O. Korsgren Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice J Exp Med 189 1999 553 562
78. Matsuda H, Suda T, Sato J, Nagata T, Koide Y, Chida K, Nakamura H. α-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am J Respir Cell Mol Biol, in press.
79. O. Akbari, P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M.J. Grusby, R.H. DeKruyff, and D.T. Umetsu Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity Nat Med 9 2003 582 588
80. M. Lisbonne, S. Diem, K.A. de Castro, J. Lefort, L.M. Araujo, P. Hachem, J.M. Fourneau, S. Sidobre, M. Kronenberg, M. Taniguchi, P. Van Endert, M. Dy, P. Askenase, M. Russo, B.B. Vargaftig, A. Herbelin, and M.C. Leite-de-Moraes Cutting edge: invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model J Immunol 171 2003 1637 1641
81. J.O. Kim, D.H. Kim, W.S. Chang, C. Hong, S.H. Park, S. Kim, and C.Y. Kang Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model J Allergy Clin Immunol 114 2004 1332 1338
82. Y. Ikegami, A. Yokoyama, Y. Haruta, K. Hiyama, and N. Kohno Circulating natural killer T cells in patients with asthma J Asthma 41 2004 877 882
83. A.S. Major, M.T. Wilson, J.L. McCaleb, S.Y. Ru, A.K. Stanic, S. Joyce, L. Van Kaer, S. Fazio, and M.F. Linton Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 24 2004 2351 2357
84. K. Takeda, Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura Critical contribution of liver natural killer T cells to a murine model of hepatitis Proc Natl Acad Sci USA 97 2000 5498 5503
85. Y. Kaneko, M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, and M. Taniguchi Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis J Exp Med 191 2000 105 114
86. A.C. Chernavsky, N. Paladino, A.E. Rubio, M.B. De Biasio, N. Periolo, M. Cuarterolo, J. Goni, C. Galoppo, M.C. Canero-Velasco, A.E. Munoz, H. Fainboim, and L. Fainboim Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children Hum Immunol 65 2004 683 691
87. S.M. Behar, C.C. Dascher, M.J. Grusby, C.R. Wang, and M.B. Brenner Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis J Exp Med 189 1999 1973 1980
88. I. Sugawara, H. Yamada, S. Mizuno, C.Y. Li, T. Nakayama, and M. Taniguchi Mycobacterial infection in natural killer T cell knockout mice Tuberculosis 82 2002 97 104
89. J.L. Gansert, V. Kiessler, M. Engele, F. Wittke, M. Rollinghoff, A.M. Krensky, S.A. Porcelli, R.L. Modlin, and S. Stenger Human NKT cells express granulysin and exhibit antimycobacterial activity J Immunol 170 2003 3154 3161
90. F. Dieli, M. Taniguchi, M. Kronenberg, S. Sidobre, J. Ivanyi, L. Fattorini, E. Iona, G. Orefici, G. De Leo, D. Russo, N. Caccamo, G. Sireci, C. Di Sano, and A. Salerno An anti-inflammatory role for Vα14 NK T cells in Mycobacterium bovis bacillus Calmette-Guerin-infected mice J Immunol 171 2003 1961 1968
91. K. Kawakami, Y. Kinjo, K. Uezu, S. Yara, K. Miyagi, Y. Koguchi, T. Nakayama, M. Taniguchi, and A. Saito Minimal contribution of Vα14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice Microbiol Immunol 46 2002 207 210
92. + natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection Eur J Immunol 33 2003 3322 3330
93. E.E. Nieuwenhuis, T. Matsumoto, M. Exley, R.A. Schleipman, J. Glickman, D.T. Bailey, N. Corazza, S.P. Colgan, A.B. Onderdonk, and R.S. Blumberg CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung Nat Med 8 2002 588 593
94. S. Minagawa, C. Ohyama, S. Hatakeyama, N. Tsuchiya, T. Kato, and T. Habuchi Activation of natural killer T cells by α-galactosylceramide mediates clearance of bacteria in murine urinary tract infection J Urol 173 2005 2171 2174
95. H. Kumar, A. Belperron, S.W. Barthold, and L.K. Bockenstedt Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi J Immunol 165 2000 4797 4801
96. G. Gonzalez-Aseguinolaza, C. de Oliveira, M. Tomaska, S. Hong, O. Bruna-Romero, T. Nakayama, M. Taniguchi, A. Bendelac, L. Van Kaer, Y. Koezuka, and M. Tsuji α-galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria Proc Natl Acad Sci USA 97 2000 8461 8466
97. D.S. Hansen, M.A. Siomos, L. Buckingham, A.A. Scalzo, and L. Schofield Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex Immunity 18 2003 391 402
98. + Vα14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major Int Immunol 12 2000 1267 1274
99. J.L. Amprey, J.S. Im, S.J. Turco, H.W. Murray, P.A. Illarionov, G.S. Besra, S.A. Porcelli, and G.F. Spath A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan J Exp Med 200 2004 895 904
100. M.S. Duthie, M. Wleklinski-Lee, S. Smith, T. Nakayama, M. Taniguchi, and S.J. Kahn During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein Infect Immun 70 2002 36 48
101. Y. Miyahira, M. Katae, K. Takeda, H. Yagita, K. Okumura, S. Kobayashi, T. Takeuchi, T. Kamiyama, Y. Fukuchi, and T. Aoki Activation of natural killer T cells by α-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi Infect Immun 71 2003 1234 1241
102. Y. Nakano, H. Hisaeda, T. Sakai, H. Ishikawa, M. Zhang, Y. Maekawa, T. Zhang, M. Takashima, M. Nishitani, R.A. Good, and K. Himeno Roles of NKT cells in resistance against infection with Toxoplasma gondii and in expression of heat shock protein 65 in the host macrophages Microbes Infect 4 2002 1 11
103. Y. Nakano, H. Hisaeda, T. Sakai, M. Zhang, Y. Maekawa, T. Zhang, and K. Himeno Role of innate immune cells in protection against Toxoplasma gondii at inflamed site J Med Invest 48 2001 73 80
104. + natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans Infect Immun 69 2001 213 220
105. + NKT cells during HIV type 1 infection J Immunol 168 2002 1490 1495
106. + Vα24 natural killer T cells in human immunodeficiency virus infection J Virol 76 2002 7528 7534
107. R. Fleuridor, B. Wilson, R. Hou, A. Landay, H. Kessler, and L. Al Harthi CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection Immunology 108 2003 3 9
108. K. Kakimi, L.G. Guidotti, Y. Koezuka, and F.V. Chisari Natural killer T cell activation inhibits hepatitis B virus replication in vivo J Exp Med 192 2000 921 930
109. K. Kakimi, T.E. Lane, F.V. Chisari, and L.G. Guidotti Cutting edge: inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver J Immunol 167 2001 6701 6705
110. + T cells and rapid elimination of effector cells by apoptosis Eur J Immunol 28 1998 3448 3455
111. + NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients Clin Immunol 114 2005 183 189
112. M. Lucas, S. Gadola, U. Meier, N.T. Young, G. Harcourt, A. Karadimitris, N. Coumi, D. Brown, G. Dusheiko, V. Cerundolo, and P. Klenerman Frequency and phenotype of circulating Vα24/Vβ11 double-positive natural killer T cells during hepatitis C virus infection J Virol 77 2003 2251 2257
113. M.A. Exley, N.J. Bigley, O. Cheng, S.M. Tahir, S.T. Smiley, Q.L. Carter, H.F. Stills, M.J. Grusby, Y. Koezuka, M. Taniguchi, and S.P. Balk CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus J Leukoc Biol 69 2001 713 718
114. + T cells and amplification of antiviral immune responses to respiratory syncytial virus J Virol 76 2002 4294 4303
115. B. Grubor-Bauk, A. Simmons, G. Mayrhofer, and P.G. Speck Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Vα14-Jα281 TCR J Immunol 170 2003 1430 1434
116. A.A. Ashkar, and K.L. Rosenthal Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection J Virol 77 2003 10168 10171
117. Y. Hayakawa, S. Rovero, G. Forni, and M.J. Smyth α- Galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis Proc Natl Acad Sci USA 100 2003 9464 9469
118. M.J. Smyth, K.Y. Thia, S.E. Street, E. Cretney, J.A. Trapani, M. Taniguchi, T. Kawano, S.B. Pelikan, N.Y. Crowe, and D.I. Godfrey Differential tumor surveillance by natural killer (NK) and NKT cells J Exp Med 191 2000 661 668
119. S. Gillessen, Y.N. Naumov, E.E. Nieuwenhuis, M.A. Exley, F.S. Lee, N. Mach, A.D. Luster, R.S. Blumberg, M. Taniguchi, S.P. Balk, J.L. Strominger, G. Dranoff, and S.B. Wilson CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion Proc Natl Acad Sci USA 100 2003 8874 8879
120. + NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load Int J Cancer 116 2005 87 93
121. S. Motohashi, S. Kobayashi, T. Ito, K.K. Magara, O. Mikuni, N. Kamada, T. Iizasa, T. Nakayama, T. Fujisawa, and M. Taniguchi Preserved IFN-α production of circulating Vα24 NKT cells in primary lung cancer patients Int J Cancer 102 2002 159 165
122. K.M. Dhodapkar, B. Cirignano, F. Chamian, D. Zagzag, D.C. Miller, J.L. Finlay, and R.M. Steinman Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion Int J Cancer 109 2004 893 899
123. M.V. Dhodapkar, M.D. Geller, D.H. Chang, K. Shimizu, S. Fujii, K.M. Dhodapkar, and J. Krasovsky A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma J Exp Med 197 2003 1667 1676